CEimpact Podcast

This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable positive impacts on HF-related measures. What does this mean for the larger health quality landscape?   The GameChanger Quality in healthcare is rapidly evolving. There are pressures at the population le...

The anti-rejection drug rapamycin has been shown in mice and other mammals to reverse cellular damage caused by aging to extend healthy life by up to 20%. This has caused massive off-label prescribing and use of rapamycin in humans as an anti-aging drug.   The GameChanger What do you tell patients about the evidence-based use of rapamycin for anti-aging?   Host Geoff Wall, PharmD, BCPS, FCCP, BCGP...

In this episode, we delve into the crucial topic of understanding generational differences in the context of pharmacy education. Our guest expert, Melissa Medina from the University of Oklahoma, brings a wealth of knowledge and experience to the table, shedding light on why grasping these generational nuances is paramount for preceptors working with pharmacy students and residents. Tune in to gain...

The GameChanger A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.  ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.   Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health   Reference Study: https://www.nej...

Stay updated on recently FDA-approved medications crucial for pharmacists. Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.   The GameChanger SweatControl Patch approved for primary axillary hyperhidrosis. Update in treatment for Alzheimer's with mild cognitive impairment.   Host Joe Strain, PharmD Clinica...

The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population.  We will discuss this scorin...

Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography. THE GAMECHANGER:   Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches...

Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners.   Kathy Schott, PhD Vice...

With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.   The GameChanger Measles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.   Geoff Wall, PharmD...

With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr! The GameChangers:   Frostbite prevention using layers and heating measures Hypothermia treatment using external and internal heating  Frostbite treatment with anticoagulants   Host Geoff Wal...

The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.   The GameChanger Diabetes treatment is shifting to prevention and delay. After a long period of time w...

Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall. The GameChanger Insulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis sugges...

Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new  American College of Gastroenterology guidelines.   The GameChanger The MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorde...

Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes. On this episode, guest Chris...

Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides.   The GameChanger Thiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously repor...

Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.   The GameChanger CRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.   Host Geoff Wa...

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode. The GameChanger Rate and rhythm control medications largely have the same clinical outcomes. Patients with heart f...

Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode. The GameChanger Different stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as fir...

Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding studen...

Join Ashlee as she talks with Ina, the Director of Clinical Operations at RxGenomix, about the fascinating world of pharmacogenomics. Throughout this episode, Ashlee and Ina get into the nitty-gritty of pharmacogenomic testing - a game-changer in ensuring the right medication is administered to the right patient at the right time and dose. Listen to this episode to equip yourself with the knowledg...

One of the oldest medications in our pharmacopeia is digoxin. It may be used for atrial fibrillation and heart failure, although not as a first-line agent. Despite this, digoxin use is on the rise. Join host, Geoff Wall, as he evaluates why more prescribers are using digoxin. The GameChanger No new randomized controlled trials have been published to justify the increased use of digoxin. However, w...

Join Ashlee as she talks with Jen Moulton, the president of CEimpact, about her top five takeaways from a transformative year in pharmacy education and patient care.  Listen to this episode to reflect on, learn, and apply the biggest lessons 2023 taught us, from the every-day practices that define us to the big picture within pharmacy education that leads us.  In this episode, the two discuss: - T...

Alzheimer's Disease is a progressive terminal disease. Many treatments are focused on lifestyle modification to delay diagnosis and onset. Join host, Geoff Wall, with guest Jake Galdo, as they look at a new study evaluating the association between vaccines and the development of Alzheimer's Disease.   The GameChanger Postviral inflammation may play a role in the development of Alzheimer&...

Exocrine enzyme dysfunction is far more common than many primary care practitioners realize. Using pancreatic enzymes can help with symptoms and vitamin absorption. Join host, Geoff Wall, as he reviews new guidelines on the appropriate use of pancreatic enzymes.   The GameChanger Chronic pancreatitis is the most common cause of exocrine dysfunction in adults. All pancreatic enzymes are equally eff...

The world of healthcare is changing and so are our students and residents. If you are in a precepting role, you are experiencing some challenges in navigating these new waters. In this episode, Logan Murry, CPD champion, makes professional development practical, effective, and intentional. Listen in to learn how taking time to practice intentional CPD can make you a more effective, and more fulfil...